Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2001;86:605-606; doi:10.1136/heart.86.6.605
Copyright © 2001 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2001;86:605-606 ( December )

Editorial

Inflammatory role of platelets in acute coronary syndromes

The first 150 words of the full text of this article appear below.

Increasing evidence shows that inflammatory mediators play a pathogenic role in atherogenesis and acute coronary syndrome.1 In particular, several reports suggest that inflammatory cytokines such as tumour necrosis factor alpha  (TNFalpha ), interleukin (IL)-1 and various chemokines (for example, IL-8) may enhance degradation of the connective tissue matrix protein by activating matrix metalloproteinases (MMPs) and induce apoptosis of cells within the atherosclerotic lesion, promoting plaque destabilisation and rupture.1 2 These findings indicate a pathogenic link between persistent immune activation and plaque rupture in coronary artery disease. It is well established that platelets also contribute to the pathogenesis of acute coronary syndromes by promoting thrombus formation. However, recent studies suggest that these cells also may trigger an acute coronary event through other mechanisms, such as stimulation of an inflammatory response within the atherosclerotic plaque.

Platelets as inflammatory cells

Several lines of evidence support a role for platelets as inflammatory cells. Firstly, platelets provide . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Iijima, R, Byrne, R A, Ndrepepa, G, Braun, S, Mehilli, J, Berger, P B, Schomig, A, Kastrati, A (2009). Pre-procedural C-reactive protein levels and clinical outcomes after percutaneous coronary interventions with and without abciximab: pooled analysis of four ISAR trials. Heart 95: 107-112 [Abstract] [Full Text]  
  • O'Kennedy, N., Crosbie, L., Whelan, S., Luther, V., Horgan, G., Broom, J. I, Webb, D. J, Duttaroy, A. K (2006). Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans.. Am. J. Clin. Nutr. 84: 561-569 [Abstract] [Full Text]  
  • Otterdal, K., Smith, C., Oie, E., Pedersen, T. M., Yndestad, A., Stang, E., Endresen, K., Solum, N. O., Aukrust, P., Damas, J. K. (2006). Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes. Blood 108: 928-935 [Abstract] [Full Text]  
  • Chakrabarti, S., Varghese, S., Vitseva, O., Tanriverdi, K., Freedman, J. E. (2005). CD40 Ligand Influences Platelet Release of Reactive Oxygen Intermediates. Arterioscler. Thromb. Vasc. Bio. 25: 2428-2434 [Abstract] [Full Text]  
  • Aukrust, P., Damas, J. K., Solum, N. O. (2004). Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?. J Am Coll Cardiol 43: 2326-2328 [Full Text]  
  • Nannizzi-Alaimo, L., Alves, V. L., Phillips, D. R. (2003). Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation. Circulation 107: 1123-1128 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.